Lexicon Pharmaceuticals (LXRX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.01 -1.47%
EPS Growth %: -600.0%
Financial Fact:
Total revenues: 27.72M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -600.0%
Financial Fact:
Total revenues: 27.72M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $355 thousand versus the consensus estimate of $320 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Coffee Holding Co. (JVA) Reports Q2 EPS of $0.05
- Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
